A favipiravir-induced angioedema and urticaria in a COVID-19 patient.
- Published in:
- Antiviral Therapy, 2022, v. 27, n. 6, p. 1, doi. 10.1177/13596535221146226
- By:
- Publication type:
- Article
Works matching IS 13596535 AND DT 2022 AND VI 27 AND IP 6
Results: 4
1
2
Letermovir use to treat complex cytomegalovirus reactivations in two heart transplant recipients.
- Published in:
- Antiviral Therapy, 2022, v. 27, n. 6, p. 1, doi. 10.1177/13596535221133619
- By:
- Publication type:
- Article
3
EDP-514 in healthy subjects and nucleos(t)ide reverse transcriptase inhibitor-suppressed patients with chronic hepatitis B.
- Published in:
- Antiviral Therapy, 2022, v. 27, n. 6, p. 1, doi. 10.1177/13596535221127848
- By:
- Publication type:
- Article
4
Understanding the effect of direct-acting antiviral therapy on weight in patients with chronic hepatitis C.
- Published in:
- Antiviral Therapy, 2022, v. 27, n. 6, p. 1, doi. 10.1177/13596535221115253
- By:
- Publication type:
- Article